• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bolt Biotherapeutics, Inc. - Common Stock (NQ:BOLT)

4.910 -0.150 (-2.96%)
Delayed Quote Updated: 4:00 PM EST, Nov 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 60,411
Open 5.050
Bid (Size) 4.910 (400)
Ask (Size) 5.060 (100)
Prev. Close 5.060
Today's Range 4.870 - 5.210
52wk Range 3.100 - 7.780
Shares Outstanding 37,950,986
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Unusual Volume in Small-Cap US Stocks: Mixed Session of Gains and Sharp Losses ↗
October 26, 2026
Via Chartmill
News headline image
Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
November 12, 2025
From Bolt Biotherapeutics, Inc.
Via GlobeNewswire

Performance

52-Week Range 36.9% below 52-week high
4.910
3.1052W Low 7.7852W High
1 Week 20.8% below 1-week high
5.061W Low 6.201W High

Bolt Biotherapeutics, Inc. - Common Stock (BOLT) traded between $3.10 and $7.78 over the past 52 weeks and last traded at $4.91, 36.9% below its 52-week high. Over the past week it ranged between $5.06 and $6.20.

Past 12 Months
-19.2%
+13.9%
+53.4%
+7.0%
-15.2%
+4.9%
1W -$1.17
1M +$0.60
3M +$1.71
6M +$0.32
YTD -$0.88
1Y +$0.23

BOLT was +4.9% over the past year, +7.0% over six months, -15.2% year to date, -19.2% in the last week.

12 Months vs Market
BOLT
+4.9%
DIA
+4.2%
SPY
+4.1%
QQQ
+1.4%
IWM
+9.9%

Over the past 12 months BOLT returned +4.9% versus DIA (Dow) +4.2%, SPY (S&P 500) +4.1%, QQQ (Nasdaq 100) +1.4% and IWM (Russell 2000) +9.9%.

Volume & Liquidity 0.24× 3-mo avg
Today 60,411 3-mo avg 253.9K
1W
73.8K
1M
663.5K
3M
253.9K
6M
142.1K
YTD
92.3K
1Y
87.2K

BOLT most recently traded 60,411 shares against a 3-month average daily volume of 253.9K.

More News

Read More
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
October 02, 2025
Via Benzinga
News headline image
Fidus Investment, Rocket Companies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
October 02, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
October 02, 2025
Via Benzinga
News headline image
Why Concorde International Group Shares Are Trading Higher By 55%; Here Are 20 Stocks Moving Premarket ↗
October 02, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
October 01, 2025
Via Benzinga
News headline image
Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027
October 01, 2025
From Bolt Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
August 28, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
August 27, 2025
Via Benzinga
News headline image
Bolt Revenue Jumps 39 Percent in Q2 ↗
August 14, 2025
Via The Motley Fool
News headline image
Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
August 14, 2025
From Bolt Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
August 01, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
June 04, 2025
Via Benzinga
News headline image
Stay updated with the stocks that are on the move in today's after-hours session. ↗
June 04, 2025
Via Chartmill
News headline image
Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
May 12, 2025
From Bolt Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates
May 08, 2025
From Bolt Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025
April 30, 2025
From Bolt Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025
April 25, 2025
From Bolt Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025
March 25, 2025
From Bolt Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
March 24, 2025
From Bolt Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Bolt Biotherapeutics to Participate in Upcoming March Conferences
February 25, 2025
From Bolt Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.
February 11, 2025
From Bolt Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
November 12, 2024
From Bolt Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting
November 07, 2024
From Bolt Biotherapeutics, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Bolt Biotherapeutics, Inc. - Common Stock publicly traded?
Yes, Bolt Biotherapeutics, Inc. - Common Stock is publicly traded.
What exchange does Bolt Biotherapeutics, Inc. - Common Stock trade on?
Bolt Biotherapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Bolt Biotherapeutics, Inc. - Common Stock?
The ticker symbol for Bolt Biotherapeutics, Inc. - Common Stock is BOLT on the Nasdaq Stock Market
What is the current price of Bolt Biotherapeutics, Inc. - Common Stock?
The current price of Bolt Biotherapeutics, Inc. - Common Stock is 4.910
When was Bolt Biotherapeutics, Inc. - Common Stock last traded?
The last trade of Bolt Biotherapeutics, Inc. - Common Stock was at 11/20/26 04:00 PM ET
What is the market capitalization of Bolt Biotherapeutics, Inc. - Common Stock?
The market capitalization of Bolt Biotherapeutics, Inc. - Common Stock is 186.34M
How many shares of Bolt Biotherapeutics, Inc. - Common Stock are outstanding?
Bolt Biotherapeutics, Inc. - Common Stock has 186M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap